Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
about
Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Classic Hodgkin Lymphoprolifer ...... th Bendamustine Plus Rituximab
@en
Classic Hodgkin Lymphoprolifer ...... th Bendamustine Plus Rituximab
@nl
type
label
Classic Hodgkin Lymphoprolifer ...... th Bendamustine Plus Rituximab
@en
Classic Hodgkin Lymphoprolifer ...... th Bendamustine Plus Rituximab
@nl
prefLabel
Classic Hodgkin Lymphoprolifer ...... th Bendamustine Plus Rituximab
@en
Classic Hodgkin Lymphoprolifer ...... th Bendamustine Plus Rituximab
@nl
P2093
P2860
P356
P1433
P1476
Classic Hodgkin Lymphoprolifer ...... th Bendamustine Plus Rituximab
@en
P2093
Hiroaki Inoue
Hirokazu Tanaka
Itaru Matsumura
Ko Fujimoto
Naoya Nakamura
Ryota Matsuoka
Takahiro Kumode
Takashi Ashida
Yasuhiro Taniguchi
Yasuyoshi Morita
P2860
P356
10.3390/CANCERS10090304
P407
P577
2018-09-03T00:00:00Z